NovaBay Pharmaceuticals Inc
NBY
|
|
| |
|
| Trading Volume | 40,100 |
|
|
0.00 - 0.00 |
| Market Cap Full | $ 10.8M |
Quarterly +
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Q1 | - | - | - | -18.8% |
| Q2 | - | - | - | -17.5% |
| Q3 | - | - | - | 1440% |
| Q4 | - | - | - | -56.9% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| - | - | - | - | - | - | - | - | - | - | - | - |
| 2023 | |||||||||||
| - | - | - | - | - | - | - | - | - | - | - | - |
| 2022 | |||||||||||
| -19 | 6 | -5.3 | -22.1 | -15.3 | 25 | -4 | - | 1504.2 | - | -45.2 | -21.3 |
| 2021 | |||||||||||
| 27.1 | 27 | -18.9 | -10.5 | -13.4 | -5.6 | 3 | -2.5 | -4.6 | -17.5 | -5.7 | -25.4 |
| 2020 | |||||||||||
| -8.7 | -1.9 | 5.4 | 53.4 | -8.2 | 36.1 | 7 | -26 | -18.8 | -17.7 | 2 | 12.9 |
EPS
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Q1 | -0.9 | 0 | -0 | -0.1 |
| Q2 | -1.3 | -1.4 | -0 | -0.2 |
| Q3 | -0.4 | -3.5 | -0.1 | -0.1 |
| Q4 | 0 | -5.2 | -0.7 | -0 |
| A | -2.49 | -10.1 | -0.8 | -0.3 |